Consent Form - Emmes

TREATMENT REFERRAL CENTER PROTOCOL – TRC 9701. COMPOUND 506U78 (NSC 686673) IN PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ALL OR T-CELL LYMPHOBLASTIC LYMPHOMA. This is a clinical trial called a Treatment Referral Center Protocol (a type of research study). A treatment Referral Center Protocol is a way that the National Cancer Institute works ... ................
................